Industry rejects call for transparency over use of strategy that can delay competition from generic medicines
Big Pharma fights patent disclosure demand from investors
Recent Posts
- British politicians have the wrong kind of money on the brain
- Senior loans, like airport lounges, are losing their elite status
- Pressure grows on Starmer over Mandelson due diligence
- Russia rakes in $150mn a day in extra revenue from surging oil prices
- Estée Lauder sues perfumer Jo Malone for breach of contract
